Australia News
-
Novogen progresses on drugs against genetic, degenerative disorders
Australia | News | By BioSpectrum Bureau | 0 Comment | 14 Nov, 2013
Singapore: Australian company Novogen, engaged in a pilot program aimed at breakthrough development of drugs to treat a wide range of genetic and non-genetic degenerative diseases, has met ...Read more
-
Australia | News | By Aishwarya Venkatesh | 0 Comment | 19 Aug, 2016
Singapore: WHO estimates that globally, nearly 350 million people suffer from depression. As explained by the health governing bodies, depression is a common illness worldwide and is differ...Read more
-
Lab-to-market is a challenge for Aussie researchers
Australia | News | By BioSpectrum Bureau | 0 Comment | 12 Oct, 2012
Australia: Mr David Henderson, MD of UniQuest, which is one of the technology transfer companies in the Asia Pacific region, believes that tech transfer organizations act as the pivotal poi...Read more
-
Vaxxas' painless vaccine delivery tech fetches BioSpectrum award
Australia | Influencers | By BioSpectrum Bureau | 0 Comment | 15 Mar, 2013
Prof Mark Kendall, a scientist at the Australian Institute of Bioengineering and Nanotechnology under University of Queensland, came up with the idea of nanopatch technology in 2003. The te...Read more
-
Bone Medical reveals results of arthritis study
Australia | News | By BioSpectrum Bureau | 0 Comment | 30 Jan, 2013
Singapore: Australia-based Bone Medical, a biopharmaceutical company focused on the development of new medicines for musculoskeletal diseases, revealed its initial findings from a proof-of-...Read more
-
Stem cell study reveals potential diabetes cure
Australia | News | By BioSpectrum Bureau | 0 Comment | 03 Dec, 2012
Singapore: A research conducted by Australian scientists on stem cells has shown that patients suffering from type 1 diabetes have the ability to make their own insulin thus erasing the nee...Read more
-
Aussie firm grows human tendons in lab
Australia | News | By BioSpectrum Bureau | 0 Comment | 10 Nov, 2014
Australia: Australia based regenerative medicine company, Orthocell, has successfully grown human tendons in a laboratory. The research was conducted in collaboration between Orthocell, Un...Read more
-
Australia announces victory over AIDS
Australia | News | By BioSpectrum Bureau | 0 Comment | 14 Jul, 2016
Singapore: Ahead of the 21st International AIDS Conference, a team of Australian researchers and experts from the Australian Federation of Aids Organisations have made an announcement stati...Read more
-
There's still time to stop TPP from cutting off critical affordable generic medicines: MSF
Australia | News | By BioSpectrum Bureau | 0 Comment | 05 Feb, 2016
Singapore: As representatives from the United States and 11 other Pacific-Rim countries gather in New Zealand to sign the Trans-Pacific Partnership (TPP) trade agreement today, the fight to...Read more
-
Luye Medical integrates Australia's Healthe Care to its group
Australia | News | By BioSpectrum Bureau | 0 Comment | 05 May, 2016
Healthe Care, Australia's third largest private healthcare group, officially became a member of Singapore-headquartered, Luye Medical Group Pte Ltd after the AU $938 million acquisition fro...Read more
-
India, Australia partner to foster sugar research
Australia | News | By BioSpectrum Bureau | 0 Comment | 04 May, 2016
Singapore: Sugar Research Australia recently announced a new research partnership with India to further research and foster the development of new sugarcane varieties. The team aims to focu...Read more
-
QRxPharma, FDA clarify steps for Moxduo release
Australia | News | By BioSpectrum Bureau | 0 Comment | 17 Jan, 2013
Singapore: QRxPharma has clarified with the US FDA about the steps necessary for approval of immediate release Moxduo. QRxPharma will resubmit its NDA this quarter, with an expected new PD...Read more
-
Australia's power woman Deborah Rathjen wins BioSpectrum award
Australia | Influencers | By BioSpectrum Bureau | 0 Comment | 15 Mar, 2013
Steering Bionomics' focus towards large markets where there is a defined clinical need for new treatments, Dr Rathjen helped it gain global recognition for its multiple drug candidates and ...Read more
-
Cytori, Lorem to commercialize Cytori Cell Therapy
Australia | News | By BioSpectrum Bureau | 0 Comment | 05 Nov, 2013
Singapore: US-based Cytori Therapeutics and China-based Lorem Vascular have formed a partnership to commercialize Cytori Cell Therapy for the cardiovascular, renal and diabetes markets in C...Read more
-
Australian TGA nod for superbug antibiotic
Australia | Regulatory | By BioSpectrum Bureau | 0 Comment | 26 Apr, 2013
Singapore: An effective new antibiotic designed to specifically treat Clostridium difficile-associated diarrhoea will be available to patients in Australia from 14th May 2013. Specialized T...Read more
-
Generon initiates phase I clinical study for F-652 in Australia
Australia | News | By BioSpectrum Bureau | 0 Comment | 06 Sep, 2012
Singapore: Generon (Shanghai)has initiated phase I clinical trial for F-652 in Australia. F-652 is a recombinant protein containing a human interleukin-22 (IL-22) dimer. The current phase I...Read more
-
Aus drug delivery technology gets Chinese patent
Australia | News | By BioSpectrum Bureau | 0 Comment | 30 Apr, 2013
Singapore: Australian drug delivery technology company Imugene has received key Chinese patent application for the company's novel drug delivery technology Linguet. The Chinese application...Read more
-
Post-chemotherapy pain killer trial begins
Australia | News | By BioSpectrum Bureau | 0 Comment | 11 Dec, 2012
Singapore: Spinifex Pharmaceuticals, an Australian pain drug development company, announced that the first set of patients have been treated in its phase II study of EMA401 in chemotherapy...Read more
